Soligenix
SNGX
#10288
Rank
ยฃ8.38 M
Marketcap
ยฃ0.83
Share price
0.90%
Change (1 day)
-56.94%
Change (1 year)

EPS for Soligenix (SNGX)

EPS in 2025 (TTM): -ยฃ2.43

According to Soligenix's latest financial reports the company's current EPS (TTM) is -ยฃ2.41. In 2024 the company made an earnings per share (EPS) of -ยฃ3.70 an increase over its 2023 EPS that were of -ยฃ9.40.

EPS history for Soligenix from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-ยฃ2.43-34.22%
2024-ยฃ3.70-60.66%
2023-ยฃ9.40-83.55%
2022-ยฃ57.1413.95%
2021-ยฃ50.14-56.03%
2020-ยฃ114.0333.33%
2019-ยฃ85.52-29.41%
2018-ยฃ121.16-41.38%
2017-ยฃ206.6824.73%
2016-ยฃ165.70-69%
2015-ยฃ534.53-6.25%
2014-ยฃ570.16-50.77%
2013-ยฃ1,15875.68%
2012-ยฃ659.2568.18%
2011-ยฃ391.99-69.86%
2010-ยฃ1,301-8.75%
2009-ยฃ1,42533.33%
2008-ยฃ1,069-57.14%
2007-ยฃ2,494-46.15%
2006-ยฃ4,63344.44%
2005-ยฃ3,207-40.7%
2004-ยฃ5,409-15.62%
2003-ยฃ6,410-25.52%
2002-ยฃ8,607-80.94%
2001-ยฃ45,154160.89%
2000-ยฃ17,307-40.57%
1999-ยฃ29,121-63.84%
1998-ยฃ80,536601.73%
1997-ยฃ11,477101.7%
1996-ยฃ5,690

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
ยฃ8.27-443.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
ยฃ1.01-141.98%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
ยฃ1.53-163.74%๐Ÿ‡ซ๐Ÿ‡ท France
Onconova Therapeutics
ONTX
-ยฃ0.71-70.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
-ยฃ1.51-37.35%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ0.92-138.27%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Emergent BioSolutions
EBS
ยฃ1.05-143.52%๐Ÿ‡บ๐Ÿ‡ธ USA